Pediatrix Medical GroupMEX:MD 59 ROA % is 5.48% as of Mar. 2026, which is 58% above its 10-year median of 3.47. GuruFocus rates MEX:MD with a GF Score™ of 59/100 and a GF Value™ of MXN177.74. The stock has 7 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 81.34% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Pediatrix Medical Group's annualizedNet Income for the quarter that ended in Mar. 2026 was MXN2,133 Mil.
Pediatrix Medical Group's average Total Assets over the quarter that ended in Mar. 2026 was MXN38,893 Mil. Therefore, Pediatrix Medical Group's annualized ROA % for the quarter that ended in Mar. 2026 was 5.48%.
The historical rank and industry rank for Pediatrix Medical Group's ROA % or its related term are showing as below:
MEX:MD'
s ROA % Range Over the Past 10 Years
Min: -29.71 Med: 3.47 Max: 8.21
Current: 8.21
During the past 13 years, Pediatrix Medical Group's highest ROA % was 8.21%. The lowest was -29.71%. And the median was 3.47%.
MEX:MD's ROA % is ranked better than 81.34% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.75
vs MEX:MD: 8.21
Pediatrix Medical Group (MEX:MD) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Pediatrix Medical Group's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's ROA % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Pediatrix Medical Group (MEX:MD) has a ROA % of 5.48% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Pediatrix Medical Group and its competitors. This is 58% above median its historical median of 3.47. According to the industry distribution chart, Pediatrix Medical Group ranks #128 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 18.7%.
Is Pediatrix Medical Group's ROA % too high?
Pediatrix Medical Group's current ROA % of 5.48% is 58% above median its 10-year median of 3.47. The Healthcare Providers & Services industry median ROA % is 1.75. Pediatrix Medical Group's value of 5.48% is 213.1% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #128 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's ROA % compare to SGRY and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #128 out of 686 companies for ROA %. This places Pediatrix Medical Group in the top 19% of its industry — outperforming the majority of peers. The industry median ROA % is 1.75. Pediatrix Medical Group's value of 5.48% is 213.1% above this benchmark. While the company's 10-year median is 3.47 vs. the industry median of 1.75, Pediatrix Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current ROA % of 5.48% is 213.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current ROA % is 5.48%, which is 58% above median its own 10-year median of 3.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (MEX:MD) has a current ROA % of 5.48%. The stock's GF Value™ is MXN177.74, compared to a current price of MXN323.00 — trading 81.7% above its estimated fair value. The current ROA % is 5.48%, which is 58% above median its 10-year median of 3.47 and 213.1% above the Healthcare Providers & Services industry median of 1.75. Pediatrix Medical Group's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Pediatrix Medical Group (MEX:MD), the current ROA % is 5.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (MEX:MD) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of MXN323.00 is trading 81.7% above its estimated GF Value™ of MXN177.74.
Key valuation signals for MEX:MD:
ROA %: 5.48% (58% above median its 10-year median of 3.47)
GF Value™: MXN177.74 vs. price of MXN323.00 (81.7% above fair value)
Industry Position: 213.1% above the Healthcare Providers & Services median (#128 of 686)
No single metric tells the full story. See the MEX:MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
59GF Score
Get the complete analysis for MEX:MD
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MD has been successfully added to your 
